Biotech investors have had a hate/hate relationship with thestreet.com's biotech "analyst" Adam Feuerstein, as he has bashed promising companies, probably as an accomplice in bear raids against microcap biotech companies, orchestrated by shorts and hedge funds. Well, Jim Cramer's thestreet.com is about to get de-listed in an ironic comeuppance. Perhaps Cramer should have hired an analyst with a biotech background, instead of a political science hack.
http://www.zerohedge.com/article/taking-it-streetcom
He failed as a hedge fund manager before becoming a cheerleader on CNBC. And now he has failed as the CEO of an investment company. Mr. Cramer better keep his daytime job at CNBC. Booyah!
Friday, October 23, 2009
Subscribe to:
Post Comments (Atom)
Posts
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_shCacLz5yGGoqH-9btqgbdFTDyqk-XSOd7Po93fgP5Dr_rF1E_-QZgHxf5RWzP5qOMvU7ZNwHT9JuySM7UXCATFrM0zLRtHcnw1o2z2Bkv0kzGMtlmBtftDL5yigQmilXxmA=s0-d)
![[Most Recent Quotes from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tl2KRGHvRsxxtISM_o7pWjSbEv1BYCAL6lu1k5Ww44JSDsCgjZAFWUEzeLbc2fSw09oDSjr9ixEWmScM27Aom6Qg2cbD3i0k7_CkSOqvnsRZlnOJB9CK-DHTi3dpfKioxqA-dH=s0-d)
![[Most Recent USD from www.kitco.com]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_s3RW3VcgtTgVEMrX-wnH_uaBIPpzyyowaMjdF8DIfkB7H-EZu9DPg92mAFyRpvadC0uElgK91TCmJJzxac-dF-MUkdKjcLzvpDpVmqdiGHh_QrpbbLZltu=s0-d)
No comments:
Post a Comment